• Guideline Summary
  • NGC:009079
  • 2012 Feb

Pharmalgen for the treatment of bee and wasp venom allergy.

  • Guideline Summary
  • NGC:010861
  • 2015 Nov 25

Apremilast for treating moderate to severe plaque psoriasis.

  • Guideline Summary
  • NGC:009073
  • 2003 Oct (revised 2012 Apr)

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia (part review of technology appraisal guidance 70).

  • Guideline Summary
  • NGC:009332
  • 2007 Jun (revised 2012 Sep)

Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122).

  • Guideline Summary
  • NGC:006825
  • 2008 Oct (reaffirmed 2011)

Occupational therapy interventions and physical activity interventions to promote the mental wellbeing of older people in primary care and residential care.

  • Guideline Summary
  • NGC:010540
  • 2013 Aug

EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer.

  • Guideline Summary
  • NGC:010011
  • 2013 Aug

Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy.

  • Guideline Summary
  • NGC:010688
  • 2015 Mar 13

Maintaining a healthy weight and preventing excess weight gain among adults and children.

  • Guideline Summary
  • NGC:009801
  • 2013 Apr

Pirfenidone for treating idiopathic pulmonary fibrosis.

  • Guideline Summary
  • NGC:009893
  • 2013 May

Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer.

  • Guideline Summary
  • NGC:009196
  • 2012 Jun

Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital.

  • Guideline Summary
  • NGC:009800
  • 2013 April

Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures.

  • Guideline Summary
  • NGC:010961
  • 2016 Apr 27

Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated.

  • Guideline Summary
  • NGC:010892
  • 2016 Jan 27

Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases.

  • Guideline Summary
  • NGC:009518
  • 2012 Dec

Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma.